Resmetirom (REZDIFFRA): The First Approved Drug for NASH/MASH

resmetirom

once daily, oral THR β-selective agonist Ph. III for NASH opt. of triiodothyronine Lancet, December 17, 2022 Madrigal, PA / Roche, Nutley, NJ

Drug Hunter Team